Synthesis And Characterization Of Thymoquinone-Loaded Nanoparticle

Abstract

Thymoquinone (TQ), a bioactive compound derived from Nigella sativa, exhibits strong anticancer activity; however, its clinical application is limited by poor aqueous solubility and low bioavailability. In this study, an alginate-coated poly(lactic-co-glycolic acid) (PLGA) nanoparticle system was developed to improve TQ stability and provide controlled release. Nanoparticles were prepared by nanoprecipitation and characterized in terms of encapsulation efficiency, particle size, polydispersity index (PDI), zeta potential, and morphology using FTIR, SEM, and TEM. TQ quantification and release studies were performed by HPLC. The optimized nanoparticles showed a mean particle size of 178.1 ± 1.41 nm, encapsulation efficiency of 75.9 ± 0.75%, PDI of 0.4, and zeta potential of −25.55 mV. After 72 h, cumulative TQ release reached 81.7% at pH 5.5 and 75.7% at pH 7.4, indicating pH-responsive release behavior. Overall, the alginate-coated PLGA nanoparticles demonstrated potential as a controlled TQ delivery system for cancer therapy.

Keywords

• Thymoquinone
• PLGA
• Cancer
• Nanoparticle
• Drug Delivery Systems

Supporting Institution

This study was supported by the Scientific Research Projects Coordination Unit of Ege University (Project No: 29594).

Ethical Statement

Ethical approval is not required for this study, as it does not involve human participants, animal subjects, or personal data.

Thanks

The authors would like to thank the Scientific Research Projects Coordination Unit of Ege University for their support under Project No: 29594.

References

1. [1]. Kumar GV, Nair L, Sankar J, Nair SA. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Int J Nanomedicine [Internet]. 2011;9114:1685. Available from: https://doi.org/10.2147/IJN.S20165
2. [2]. Jafari-Gharabaghlou D, Dadashpour M, khanghah OJ, Salmani-Javan E, Zarghami N. Potentiation of Folate-Functionalized PLGA-PEG nanoparticles loaded with metformin for the treatment of breast Cancer: possible clinical application. Mol Biol Rep. 2023;50(4):3023–33.
3. [3]. Gali-Muhtasib H, Roessner A, Schneider-Stock R. Thymoquinone: A promising anti-cancer drug from natural sources. Int J Biochem Cell Biol. 2006;38(8):1249–53.
4. [4]. Afrose SS, Junaid M, Akter Y, Tania M, Zheng M, Khan MA. Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics. Drug Discov Today [Internet]. 2020;25(12):2294–306. Available from: https://doi.org/10.1016/j.drudis.2020.07.019
5. [5]. Nallamuthu I, Parthasarathi A, Khanum F. Thymoquinone-loaded PLGA nanoparticles: antioxidant and anti-microbial properties. Int Curr Pharm J. 2013;2(12):202–7.
6. [6]. Moghaddam FA, Ebrahimian M, Oroojalian F, Yazdian-Robati R, Kalalinia F, Tayebi L, et al. Effect of thymoquinone-loaded lipid–polymer nanoparticles as an oral delivery system on anticancer efficiency of doxorubicin. J Nanostructure Chem [Internet]. 2022;12(1):33–44. Available from: https://doi.org/10.1007/s40097-021-00398-6
7. [7]. Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, et al. Nano based drug delivery systems: Recent developments and future prospects. J Nanobiotechnology [Internet]. 2018;16(1):1–33. Available from: https://doi.org/10.1186/s12951-018-0392-8
8. [8]. Hernández-Giottonini KY, Rodríguez-Córdova RJ, Gutiérrez-Valenzuela CA, Peñuñuri-Miranda O, Zavala-Rivera P, Guerrero-Germán P, et al. PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: Effects of formulation parameters. RSC Adv. 2020;10(8):4218–31.

9. [9]. Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011;3(3):1377–97.
10. [10]. Yang J, Zeng H, Luo Y, Chen Y, Wang M, Wu C, Hu P. Recent Applications of PLGA in Drug Delivery Systems. Polymers (Basel). 2024;16(18):2606.
11. [11]. Iureva AM, Nikitin PI, Tereshina ED, Nikitin MP, Shipunova VO. The influence of various polymer coatings on the in vitro and in vivo properties of PLGA nanoparticles: Comprehensive study. Eur J Pharm Biopharm. 2024;201:114366.
12. [12]. Lai J, Azad AK, Sulaiman WMAW, Kumarasamy V, Subramaniyan V, Alshehade SA. Alginate-Based Encapsulation Fabrication Technique for Drug Delivery: An Updated Review of Particle Type, Formulation Technique, Pharmaceutical Ingredient, and Targeted Delivery System. Pharmaceutics. 2024;16(3):370.
13. [13]. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: An overview of biomedical applications. J Control Release [Internet]. 2012;161(2):505–22. Available from: http://dx.doi.org/10.1016/j.jconrel.2012.01.043
14. [14]. Davoudi Z, Peroutka-Bigus N, Bellaire B, Jergens A, Wannemuehler M, Wang Q. Gut organoid as a new platform to study alginate and chitosan mediated plga nanoparticles for drug delivery. Mar Drugs. 2021;19(5):1–15.
15. [15]. Elbialy NS, Mohamed N. Alginate-coated caseinate nanoparticles for doxorubicin delivery: Preparation, characterisation, and in vivo assessment. Int J Biol Macromol [Internet]. 2020;154:114–22. Available from: https://doi.org/10.1016/j.ijbiomac.2020.03.027
16. [16]. Abdelghany S, Parumasivam T, Pang A, Roediger B, Tang P, Jahn K, et al. Alginate modified-PLGA nanoparticles entrapping amikacin and moxifloxacin as a novel host-directed therapy for multidrug-resistant tuberculosis. J Drug Deliv Sci Technol [Internet]. 2019;52(December 2018):642–51. Available from: https://doi.org/10.1016/j.jddst.2019.05.025
17. [17]. Tiwari G, Panda S, Diyya ASM, Thomas NV, Deka T, Rudrangi SRS, et al. Design and optimization of PLGA-based gemcitabine nanocapsule for enhanced pancreatic cancer efficacy. Invest New Drugs [Internet]. 2025;43(4):800–19. Available from: https://doi.org/10.1007/s10637-025-01567-y
18. [18]. Bhattacharjee S. DLS and zeta potential - What they are and what they are not? J Control Release [Internet]. 2016;235:337–51. Available from: http://dx.doi.org/10.1016/j.jconrel.2016.06.017
19. [19]. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):1–17.
20. [20]. Sotirova Y, Stoeva S, et al. Nanostructured Lipid Carriers As a Promising Dermal Delivery Platform for St. John’S Wort Extract: Preliminary Studies. J IMAB - Annu Proceeding (Scientific Pap. 2023;29(2):4911–9.
21. [21]. Sechi M, Vanna S, Roggio AM, Siliani, Massimo P, Salvatore M, et al. Development of novel cationic chitosan- and anionic alginate–coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol. Int J Nanomedicine [Internet]. 2012;9114:5501. Available from: https://doi.org/10.2147/IJN.S36684
22. [22]. Shao L, Shen S, Liu H. Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis. Front Bioeng Biotechnol. 2022;10(July):1–17.
23. [23]. Prabha G, Raj V. Sodium alginate–polyvinyl alcohol–bovin serum albumin coated Fe3O4 nanoparticles as anticancer drug delivery vehicle: Doxorubicin loading and in vitro release study and cytotoxicity to HepG2 and L02 cells. Mater Sci Eng C [Internet]. 2017;79:410–22. Available from: http://dx.doi.org/10.1016/j.msec.2017.04.075
24. [24]. Karimi S, Rasuli H, Mohammadi R. Facile preparation of pH-sensitive biocompatible alginate beads havening layered double hydroxide supported metal-organic framework for controlled release from doxorubicin to breast cancer cells. Int J Biol Macromol [Internet]. 2023;234(October 2022):123538. Available from: https://doi.org/10.1016/j.ijbiomac.2023.123538
25. [25]. Safari Sharafshadeh M, Tafvizi F, Khodarahmi P, Ehtesham S. Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy. Int J Biol Macromol [Internet]. 2023;235(August 2022):123686. Available from: https://doi.org/10.1016/j.ijbiomac.2023.123686
26. [26]. Çetin DP, Seçme M, İlhan H, Sağlam N. Alginate and chitosan-coated ferulic acid-loaded selenium nanoparticles: synthesis, characterization, and anticancer activity against MDA-MB-231 breast cancer cells. Med Oncol. 2025;42(6).
27. [27]. Liu E, Zhao S, Li X, Meng X, Liu B. Preparation, characterization of PLGA/chitosan nanoparticles as a delivery system for controlled release of DHA. Int J Biol Macromol [Internet]. 2021;185(May):782–91. Available from: https://doi.org/10.1016/j.ijbiomac.2021.06.190
28. [28]. Kumar R, Kumar M, Luthra G. Fundamental approaches and applications of nanotechnology: A mini review. Mater Today Proc [Internet]. 2023;(xxxx). Available from: https://doi.org/10.1016/j.matpr.2022.12.172
29. [29]. Ahmad N, Ahmad R, Qatifi S Al, Alessa M, Hajji H Al, Sarafroz M. A bioanalytical UHPLC based method used for the quantification of thymoquinone-loaded-PLGA-nanoparticles in the treatment of epilepsy. BMC Chem [Internet]. 2020;14(1):1–15. Available from: https://doi.org/10.1186/s13065-020-0664-x
30. [30]. Daemi H, Barikani M. Synthesis and characterization of calcium alginate nanoparticles, sodium homopolymannuronate salt and its calcium nanoparticles. Sci Iran [Internet]. 2012;19(6):2023–8. Available from: http://dx.doi.org/10.1016/j.scient.2012.10.005
31. [31]. Kulig D, Zimoch-Korzycka A, Jarmoluk A, Marycz K. Study on alginate-chitosan complex formed with different polymers ratio. Polymers (Basel). 2016;8(5):1–17.
32. [32]. Faried M, Shameli K, Miyake M, Zakaria Z, Hara H, Ahmad Khairudin NB, et al. Ultrasound-assisted in the synthesis of silver nanoparticles using sodium alginate mediated by green method. Dig J Nanomater Biostructures. 2016;11(2):547–52.
33. [33]. Kuczajowska-Zadrożna M, Filipkowska U, Jóźwiak T. Adsorption of Cu (II) and Cd (II) from aqueous solutions by chitosan immobilized in alginate beads. J Environ Chem Eng [Internet]. 2020;8(4):103878. Available from: https://doi.org/10.1016/j.jece.2020.103878
34. [34]. Pagola S, Benavente A, Raschi A, Romano E, Molina MAA, Stephens PW. Crystal structure determination of thymoquinone by high-resolution x-ray powder diffraction. AAPS PharmSciTech. 2004;5(2):1–8.
35. [35]. Kumar SR, Thangam R, Vivek R, Srinivasan S, Ponpandian N. Synergetic effects of thymoquinone-loaded porous PVPylated Fe3O4nanostructures for efficient pH-dependent drug release and anticancer potential against triple-negative cancer cells. Nanoscale Adv. 2020;2(8):3209–21.
36. [36]. Varela-Fernández R, García-Otero X, Cuartero-Martínez A, Gómez-Lado N, González-Barcia M, Mondelo-García C, et al. Design and characterization of intravitreal bevacizumab-loaded PLGA nanoparticles: pharmacokinetic and biodistribution impact. Drug Deliv Transl Res. 2025;1262–84.
37. [37]. Ibrahim WN, Rosli LMBM, Doolaanea AA. Formulation, cellular uptake and cytotoxicity of thymoquinone-loaded plga nanoparticles in malignant melanoma cancer cells. Int J Nanomedicine. 2020;15:8059–74.
38. [38]. Rescignano N, Fortunati E, Armentano I, Hernandez R, Mijangos C, Pasquino R, et al. Use of alginate, chitosan and cellulose nanocrystals as emulsion stabilizers in the synthesis of biodegradable polymeric nanoparticles. J Colloid Interface Sci [Internet]. 2015;445:31–9. Available from: http://dx.doi.org/10.1016/j.jcis.2014.12.032
39. [39]. Choukaife H, Doolaanea AA, Alfatama M. Alginate nanoformulation: Influence of process and selected variables. Vol. 13, Pharmaceuticals. 2020. 1–35 p.
40. [40]. Islam MS, Karim MR. Fabrication and characterization of poly(vinyl alcohol)/alginate blend nanofibers by electrospinning method. Colloids Surfaces A Physicochem Eng Asp. 2010;366(1–3):135–40.
41. [41]. Ghazali NM, Aoki K, Nagao Y, Samsudin AS. Enhancing H+ conduction through glycolic acid-doped alginate-PVA based biopolymer electrolytes. Int J Hydrogen Energy [Internet]. 2024;89(September):177–89. Available from: https://doi.org/10.1016/j.ijhydene.2024.09.244
42. [42]. Noor NS, Kaus NHM, Szewczuk MR, Hamid SBS. Formulation, characterization and cytotoxicity effects of novel thymoquinone-plga-pf68 nanoparticles. Int J Mol Sci. 2021;22(17).
43. [43]. Hajian M, Erfani-Moghadam V, Arabi MS, Soltani A, Shahbazi M. A comparison between optimized PLGA and CS-Alg-PLGA microspheres for long-lasting release of glatiramer acetate. J Drug Deliv Sci Technol [Internet]. 2023;82(September 2022):104355. Available from: https://doi.org/10.1016/j.jddst.2023.104355
44. [44]. Hoseinzadeh M, Mokhtari MJ, Kafilzadeh F, Mohammadnejad J, Taheri Y. Poly lactic-co-glycolic acid-alginate nanocarrier for efficient drug delivery to liver cancer cells. IET Nanobiotechnology. 2023;17(5):450–64.
45. [45]. dos Santos Araújo P, Belini GB, Mambrini GP, Yamaji FM, Waldman WR. Thermal degradation of calcium and sodium alginate: A greener synthesis towards calcium oxide micro/nanoparticles. Int J Biol Macromol [Internet]. 2019;140:749–60. Available from: https://doi.org/10.1016/j.ijbiomac.2019.08.103
46. [46]. Kragović M, Daković A, Marković M, Petković A. Kinetic of thermal degradation of alginate-zeolite composites. Zast Mater. 2016;57(4):559–64.
47. [47]. Yang F, Stahnke R, Lawal K, Mahnen C, Duffy P, Xu S, et al. Development of poly (lactic-co-glycolic acid) (PLGA) based implants using hot melt extrusion (HME) for sustained release of drugs: The impacts of PLGA’s material characteristics. Int J Pharm [Internet]. 2024;663(August):124556. Available from: https://doi.org/10.1016/j.ijpharm.2024.124556
48. [48]. Chen B, Costello MA, Kuehster L, Lynd NA, Qin B, Wang Y, et al. Investigation of the Thermal Stability and Hydrolytic Degradation Kinetics of Poly(Lactide-co-Glycolide) Melts. AAPS PharmSciTech [Internet]. 2025;26(1):11–3. Available from: https://doi.org/10.1208/s12249-024-03018-y
49. [49]. Wawszczak A, Czemierska M, Jarosz-Wilkołazka A, Kołodyńska D. Comprehensive Physicochemical Analysis of Polyphosphate-Modified Alginate Matrices: Synthesis, Structural Analysis, and Calcium Ion Release Dynamics. Materials (Basel). 2025;18(5).
50. [50]. Shobegar EM, Ghahfarokhi SEM, Motamedi H. Fabrication of structural, and magnetic properties of CaFe2O4@SiO2-sodium alginate nanocomposite and the effect of heat treatment on its stability. Mater Chem Phys [Internet]. 2025;333(September 2024):130301. Available from: https://doi.org/10.1016/j.matchemphys.2024.130301
51. [51]. McCall RL, Sirianni RW. PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J Vis Exp. 2013;(82):51015.
52. [52]. Amin MK, Boateng J. Surface functionalization of PLGA nanoparticles for potential oral vaccine delivery targeting intestinal immune cells. Colloids Surfaces B Biointerfaces [Internet]. 2023;222(August 2022):113121. Available from: https://doi.org/10.1016/j.colsurfb.2022.113121
53. [53]. Wang F, Yuan J, Zhang Q, Yang S, Jiang S, Huang C. PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy. J Biomater Sci Polym Ed [Internet]. 2018;29(13):1566–78. Available from: https://doi.org/10.1080/09205063.2018.1475941
54. [54]. Omidian H, Wilson RL. PLGA-Based Strategies for Intranasal and Pulmonary Applications. Pharmaceutics. 2025;17(2):8–10.
55. [55]. Lagreca E, Onesto V, Di Natale C, La Manna S, Netti PA, Vecchione R. Recent advances in the formulation of PLGA microparticles for controlled drug delivery. Prog Biomater [Internet]. 2020;9(4):153–74. Available from: https://doi.org/10.1007/s40204-020-00139-y
56. [56]. Zeb A, Gul M, Nguyen TTL, Maeng HJ. Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research [Internet]. Vol. 52, Journal of Pharmaceutical Investigation. Springer Nature Singapore; 2022. 683–724 p. Available from: https://doi.org/10.1007/s40005-022-00584-w
57. [57]. Corrigan OI, Li X. Quantifying drug release from PLGA nanoparticulates. Eur J Pharm Sci. 2009;37(3–4):477–85.
58. [58]. Han FY, Thurecht KJ, Whittaker AK, Smith MT. Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading. Front Pharmacol. 2016;7(JUN):1–11.
59. [59]. Salmani JMM, Asghar S, Lv H, Zhou J. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light. Molecules [Internet]. 2014;19(5):5925-5939. Available from: https://doi.org/10.3390/molecules19055925
60. [60]. Chai F, Sun L, He X, Li J, Liu Y, Xiong F, et al. Doxorubicin-loaded poly (Lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications. Int J Nanomedicine [Internet]. 2017;12:1791–802. Available from: https://doi.org/10.2147/IJN.S130404
61. [61]. Dodero A, Alberti S, Gaggero G, Ferretti M, Botter R, Vicini S, et al. An Up-to-Date Review on Alginate Nanoparticles and Nanofibers for Biomedical and Pharmaceutical Applications. Adv Mater Interfaces. 2021;8(22).
62. [62]. Thai H, Thuy Nguyen C, Thi Thach L, Thi Tran M, Duc Mai H, Thi Thu Nguyen T, et al. Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo. Sci Rep. 2020;10(1):1–15.
63. [63]. Kim D, Han TH, Hong SC, Park SJ, Lee YH, Kim H, et al. PLGA microspheres with alginate-coated large pores for the formulation of an injectable depot of donepezil hydrochloride. Pharmaceutics. 2020;12(4).
64. [64]. Rezk AI, Obiweluozor FO, Choukrani G, Park CH, Kim CS. Drug release and kinetic models of anticancer drug (BTZ) from a pH-responsive alginate polydopamine hydrogel: Towards cancer chemotherapy. Int J Biol Macromol [Internet]. 2019;141:388–400. Available from: https://doi.org/10.1016/j.ijbiomac.2019.09.013
65. [65]. Palanikumar L, Al-Hosani S, Kalmouni M, Nguyen VP, Ali L, Pasricha R, et al. pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics. Commun Biol [Internet]. 2020;3(1):1–17. Available from: http://dx.doi.org/10.1038/s42003-020-0817-4
66. [66]. Karp F, Satler FS, Busatto CA, Luna JA, Estenoz DA, Turino LN. Modulating drug release from poly(lactic-co-glycolic) acid microparticles by the addition of alginate and pectin. J Appl Polym Sci. 2021;138(17):1–11.
67. [67]. Salmani JMM, Asghar S, Lv H, Zhou J. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light. Molecules. 2014;19(5):5925–39.
68. [68]. Raikar PR, Dandagi PM, Kumbar VM. An innovative synergistic combination using eudragit-coated galactosylated PLGA-pluronic nanoparticles for addressing colorectal cancer. J Drug Deliv Sci Technol [Internet]. 2024;94(November 2023):105481. Available from: https://doi.org/10.1016/j.jddst.2024.105481